Bayer Profit Margin 2011-2025 | BAYRY
Current and historical gross margin, operating margin and net profit margin for Bayer (BAYRY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Bayer net profit margin as of June 30, 2025 is -7.61%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Large Cap Pharmaceutical | $29.984B | $50.438B |
| Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eli Lilly (LLY) | United States | $913.846B | 43.96 |
| Johnson & Johnson (JNJ) | United States | $453.935B | 18.15 |
| AbbVie (ABBV) | United States | $386.545B | 23.14 |
| Roche Holding AG (RHHBY) | Switzerland | $279.027B | 0.00 |
| Novartis AG (NVS) | Switzerland | $268.700B | 14.24 |
| Merck (MRK) | United States | $215.315B | 10.03 |
| Novo Nordisk (NVO) | Denmark | $205.122B | 12.03 |
| Pfizer (PFE) | United States | $138.674B | 7.62 |
| Sanofi (SNY) | France | $124.396B | 11.95 |
| Innoviva (INVA) | United States | $1.315B | 7.82 |